COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stable chronic obstructive pulmonary disease (a long-term lung condition, often called COPD)
- People whose condition matches certain Traditional Chinese Medicine (TCM) patterns related to weakness in the lungs, lungs and spleen, or lungs and kidneys (confirm with trial site)
- People aged between 18 and 80 years old
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People who have cognitive impairment, confusion, dementia, or a mental health disorder
- People who have unstable chest pain (angina) or have recently had a heart attack
- People who have a history of fainting during exercise, or who have bone or joint conditions that would affect their ability to exercise
- People who have a collapsed lung, fluid around the lungs, a blood clot in the lungs, or a tumour
- People who are known to be allergic to any ingredients in the moxibustion powder used in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yang Xie, Doctor, the First Affiliated Hospital of Henan University of Chinese Medicine
Phone: 13526621325
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The level of plasma exosomal miR-125b; T-cell subsets and immunoglobulin levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.